LetterLetter
Effectiveness of Thrombopoietin-receptor Agonists in the Treatment of Refractory Immune Thrombocytopenia Associated to Systemic Lupus Erythematosus
LAURA MAGNANO, HECTOR ENRÍQUEZ, JORDI ESTEVE, RICARD CERVERA and GERARD ESPINOSA
The Journal of Rheumatology September 2014, 41 (9) 1895-1896; DOI: https://doi.org/10.3899/jrheum.140080
LAURA MAGNANO
Department of Hematology
MDHECTOR ENRÍQUEZ
Department of Autoimmune Diseases;
MDJORDI ESTEVE
Department of Hematology
MD, PhDRICARD CERVERA
Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Catalonia,
Spain.
MD, PhDGERARD ESPINOSA
Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Catalonia,
Spain.
MD, PhDREFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- Gonzalez-Nieto JA,
- Martin-Suarez I,
- Quattrino S,
- Ortiz-Lopez E,
- Muñoz-Beamud FR,
- Colchero-Fernandez J,
- et al.
- 7.↵
- Alkaabi JK,
- Alkindi S,
- Riyami NA,
- Zia F,
- Balla LM,
- Balla SM
- 8.↵
- Tomov S,
- Lazarchick J,
- Self SE,
- Bruner ET,
- Budisavljevic MN
- 9.↵
- 10.↵
- 11.↵
- Thota S,
- Kistangari G,
- Daw H,
- Spiro T
- 12.↵
- Kuwana K,
- Kaburaki J,
- Okazaki Y,
- Miyazaki H,
- Ikeda Y
- 13.↵
In this issue
The Journal of Rheumatology
Vol. 41, Issue 9
1 Sep 2014
Effectiveness of Thrombopoietin-receptor Agonists in the Treatment of Refractory Immune Thrombocytopenia Associated to Systemic Lupus Erythematosus
LAURA MAGNANO, HECTOR ENRÍQUEZ, JORDI ESTEVE, RICARD CERVERA, GERARD ESPINOSA
The Journal of Rheumatology Sep 2014, 41 (9) 1895-1896; DOI: 10.3899/jrheum.140080
Effectiveness of Thrombopoietin-receptor Agonists in the Treatment of Refractory Immune Thrombocytopenia Associated to Systemic Lupus Erythematosus
LAURA MAGNANO, HECTOR ENRÍQUEZ, JORDI ESTEVE, RICARD CERVERA, GERARD ESPINOSA
The Journal of Rheumatology Sep 2014, 41 (9) 1895-1896; DOI: 10.3899/jrheum.140080